Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05978050
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-07-20
Brief Title:
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Sponsor:
Biotech Pharmaceutical Co Ltd
Organization:
Biotech Pharmaceutical Co Ltd
Organization Data
Organization:
Biotech Pharmaceutical Co Ltd
Class:
OTHER
Study ID:
BPL-Nim-GC-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biotech Pharmaceutical Co Ltd
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None